HOME
SEARCH
RSS FEED
SUBSCRIBE
Search Results - peter+syapin
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Modified minocyclines for the treatment and prevention of alcohol use disorder
Technology SummaryAlcohol use disorder (AUD) affects millions of people worldwide and lacks a strong pharmaceutical option for treatment. Minocycines have been shown to have great therapeutic potential due to their positive interactions with the central nervous system, their main drawback being unwanted bactericidal effects and toxicity. This technology...
Published: 9/25/2018
|
Inventor(s):
Ted Reid
,
Susan Bergeson
,
Peter Syapin
Keywords(s):
Category(s):
Life Sciences
,
Pharmaceutical
,
Therapeutics
Modified Tetracycline for treatment of disorders involving potential inflammatory processes
Technology SummaryAlcohol use disorder (AUD) affects millions of people worldwide and lacks a strong pharmaceutical option for treatment. Minocycines have been shown to have great therapeutic potential due to their positive interactions with the central nervous system, their main drawback being unwanted bactericidal effects. This technology encompasses...
Published: 9/19/2018
|
Inventor(s):
Ted Reid
,
Susan Bergeson
,
Peter Syapin
Keywords(s):
Category(s):
Life Sciences
,
Pharmaceutical
,
Therapeutics
Repurposed use of a currently available antibiotic and analogs to reduce alcohol consumption and negative alcohol-related consequences.
The U.S. market for substance abuse treatment and diagnosis exceeds $3.1 billion annually, yet no effective drug treatment for alcoholism has been discovered that significantly reduces alcohol consumption. Researchers have re-purposed the use of an FDA approved antibiotic currently available in the market that significantly reduces alcohol consumption...
Published: 7/2/2018
|
Inventor(s):
Susan Bergeson
,
Peter Syapin
Keywords(s):
Category(s):
Pharmaceutical